Current Report Filing (8-k)
December 09 2019 - 03:35PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
December 6, 2019
Date of Report (Date of earliest event reported)
WEARABLE HEALTH
SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Nevada |
|
333-153290 |
|
26-3534190 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
2300 Yonge St., Suite 1600
Toronto, ON Canada
|
|
M4P 1E4 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code
647-272-5702
(Former name or former address, if changed since last
report)
3960 Howard Hughes Pkwy., Suite 500
Las Vegas, NV 89196
Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ¨
If an emerging growth
company, indicate by check mark if the registrant has elected not
to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. ¨
ITEM 5.02 - DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS;
ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL
OFFICERS
Effective December 6, 2019, the Company accepted the resignation of
Charles Langrill as the officer of the Company and as a member of
the Company’s board of directors. The resignation of Mr. Langrill was not
due to any disagreement with the Company on any matter relating to
its operations, policies or practices. Simultaneously, Mr. Harrysen
Mittler was elected as the Company’s Chairman, CEO, CFO and
Director, and Mr. Peter Pizzino as the Company’s President and
Director.
ITEM 7.01 - REGULATION FD DISCLOSURE
On
December 6, 2019, the Company issued a press release entitled,
“Wearable Health Solutions Inc. Announces New
Appointees.”
A copy of the press release is furnished as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference
in its entirety.
ITEM 8.01 - OTHER EVENTS
The
Company has a new corporate address located at 2300 Yonge St.,
Suite 1600, Toronto ON M4P 1E4 Canada.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
|
(b) |
Exhibits. |
|
|
|
|
|
99.1 Press
Release |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
WEARABLE HEALTH SOLUTIONS, INC.
DATE: December 9, 2019
By:
/s/ Harrysen
Mittler
Name: Harrysen Mittler
Title: CEO
Wearable Health Solutions (PK) (USOTC:WHSI)
Historical Stock Chart
From Dec 2020 to Jan 2021
Wearable Health Solutions (PK) (USOTC:WHSI)
Historical Stock Chart
From Jan 2020 to Jan 2021